Moreover, SS patients with high expression of CENPF, KIF11, KIF23, TTK, MKI67, TOP2A, CDC45, MELK, AURKB, and BUB1 predicted worse recurrence-free survival (Figure 9). This evidence concerns the gene TOP2A and synovial sarcoma.